PMC:7283670 / 45502-45716
Annnotations
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T118 | 9-18 | Chemical | denotes | Lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
T119 | 186-195 | Chemical | denotes | Lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T470 | 9-28 | Sentence | denotes | Lopinavir/Ritonavir |
T471 | 29-56 | Sentence | denotes | Results and interpretation: |
T472 | 57-214 | Sentence | denotes | significant decrease in β‐coronavirus viral loads due to the natural course of the healing process rather than administration of Lopinavir/Ritonavir, or both |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1166 | 81-94 | Species | denotes | β‐coronavirus | Tax:694002 |
1216 | 9-18 | Chemical | denotes | Lopinavir | MESH:D061466 |
1217 | 186-205 | Chemical | denotes | Lopinavir/Ritonavir | MESH:C558899 |